{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T20:05:46Z","timestamp":1766088346844,"version":"3.48.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100007785","name":"Jinan Science and Technology Bureau","doi-asserted-by":"publisher","award":["202225043"],"award-info":[{"award-number":["202225043"]}],"id":[{"id":"10.13039\/100007785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MH067"],"award-info":[{"award-number":["ZR2020MH067"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s43032-025-02000-8","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T16:00:17Z","timestamp":1762531217000},"page":"3877-3886","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Knockdown of CTMP Enhances Progesterone Sensitivity in Endometrial Cancer by Inhibiting the PI3K\/AKT Signaling Pathway"],"prefix":"10.1007","volume":"32","author":[{"given":"Xinyu","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxin","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaiyue","family":"Shang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weijia","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"2000_CR1","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::aid-cncr2820560233>3.0.co;2-x","volume":"56","author":"RJ Kurman","year":"1985","unstructured":"Kurman RJ, Kaminski PF, Norris HJ. The behavior of endometrial hyperplasia. A long-term study of untreated hyperplasia in 170 patients. Cancer. 1985;56:403\u201312. https:\/\/doi.org\/10.1002\/1097-0142(19850715)56:2%3C403::aid-cncr2820560233%3E3.0.co;2-x.","journal-title":"Cancer"},{"key":"2000_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23052531","volume":"23","author":"N-A Contreras","year":"2022","unstructured":"Contreras N-A, Sabadell J, Verdaguer P, Juli\u00e0 C, Fern\u00e1ndez-Montol\u00ed M-E. Fertility-sparing approaches in atypical endometrial hyperplasia and endometrial cancer patients: current evidence and future directions. Int J Mol Sci. 2022;23:2531. https:\/\/doi.org\/10.3390\/ijms23052531.","journal-title":"Int J Mol Sci"},{"key":"2000_CR3","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1097\/01.AOG.0000154151.14516.f7","volume":"105","author":"PT Soliman","year":"2005","unstructured":"Soliman PT, Oh JC, Schmeler KM, Sun CC, Slomovitz BM, Gershenson DM, et al. Risk factors for young premenopausal women with endometrial cancer. Obstet Gynecol. 2005;105:575\u201380. https:\/\/doi.org\/10.1097\/01.AOG.0000154151.14516.f7.","journal-title":"Obstet Gynecol"},{"key":"2000_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00428-020-03007-z","volume":"478","author":"N Concin","year":"2021","unstructured":"Concin N, Creutzberg CL, Vergote I, Cibula D, Mirza MR, Marnitz S, et al. ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma. Virchows Arch. 2021;478:153\u201390. https:\/\/doi.org\/10.1007\/s00428-020-03007-z.","journal-title":"Virchows Arch"},{"key":"2000_CR5","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/s1388-1981(02)00300-1","volume":"1584","author":"LM Neri","year":"2002","unstructured":"Neri LM, Borgatti P, Capitani S, Martelli AM. The nuclear phosphoinositide 3-kinase\/AKT pathway: a new second messenger system. Biochim Biophys Acta. 2002;1584:73\u201380. https:\/\/doi.org\/10.1016\/s1388-1981(02)00300-1.","journal-title":"Biochim Biophys Acta"},{"key":"2000_CR6","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","volume":"296","author":"LC Cantley","year":"2002","unstructured":"Cantley LC. The phosphoinositide 3-kinase pathway. Science. 2002;296:1655\u20137. https:\/\/doi.org\/10.1126\/science.296.5573.1655.","journal-title":"Science"},{"key":"2000_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/376599a0","volume":"376","author":"BM Burgering","year":"1995","unstructured":"Burgering BM, Coffer PJ. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature. 1995;376:599\u2013602. https:\/\/doi.org\/10.1038\/376599a0.","journal-title":"Nature"},{"key":"2000_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrc839","volume":"2","author":"I Vivanco","year":"2002","unstructured":"Vivanco I, Sawyers CL. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat Rev Cancer. 2002;2:489\u2013501. https:\/\/doi.org\/10.1038\/nrc839.","journal-title":"Nat Rev Cancer"},{"key":"2000_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1158\/1078-0432.CCR-21-1943","volume":"28","author":"Y Jin","year":"2022","unstructured":"Jin Y, Chen Y, Tang H, Hu X, Hubert SM, Li Q, et al. Activation of PI3K\/AKT pathway is a potential mechanism of treatment resistance in small cell lung cancer. Clin Cancer Res. 2022;28:526\u201339. https:\/\/doi.org\/10.1158\/1078-0432.CCR-21-1943.","journal-title":"Clin Cancer Res"},{"key":"2000_CR10","doi-asserted-by":"publisher","first-page":"9377","DOI":"10.3892\/ol.2018.8536","volume":"15","author":"H Zhang","year":"2018","unstructured":"Zhang H, Wang Q, Liu J, Cao H. Inhibition of the PI3K\/Akt signaling pathway reverses sorafenib-derived chemo-resistance in hepatocellular carcinoma. Oncol Lett. 2018;15:9377\u201384. https:\/\/doi.org\/10.3892\/ol.2018.8536.","journal-title":"Oncol Lett"},{"key":"2000_CR11","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3727\/096504019X15561873320465","volume":"27","author":"H Wang","year":"2019","unstructured":"Wang H, Tang Z, Li T, Liu M, Li Y, Xing B. CRISPR\/Cas9-mediated gene knockout of ARID1A promotes primary progesterone resistance by downregulating progesterone receptor B in endometrial cancer cells. Oncol Res. 2019;27:1051\u201360. https:\/\/doi.org\/10.3727\/096504019X15561873320465.","journal-title":"Oncol Res"},{"key":"2000_CR12","doi-asserted-by":"publisher","unstructured":"Gu C, Zhang Z, Yu Y, Liu Y, Zhao F, Yin L, et al. Inhibiting the PI3K\/Akt pathway reversed progestin resistance in endometrial cancer. Cancer Sci. 2011;102:557\u201364. https:\/\/doi.org\/10.1111\/j.1349-7006.2010.01829.x.","DOI":"10.1111\/j.1349-7006.2010.01829.x"},{"issue":"10","key":"2000_CR13","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012160.pub2","volume":"2019","author":"F Roncolato","year":"2019","unstructured":"Roncolato F, Lindemann K, Willson ML, Martyn J, Mileshkin L. PI3K\/AKT\/mTOR inhibitors for advanced or recurrent endometrial cancer. Cochrane Database Syst Rev. 2019;(10):CD012160. https:\/\/doi.org\/10.1002\/14651858.CD012160.pub2.","journal-title":"Cochrane Database Syst Rev"},{"key":"2000_CR14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21176073","volume":"21","author":"S Kyo","year":"2020","unstructured":"Kyo S, Nakayama K. Endometrial cancer as a metabolic disease with dysregulated PI3K signaling: shedding light on novel therapeutic strategies. Int J Mol Sci. 2020;21:6073. https:\/\/doi.org\/10.3390\/ijms21176073.","journal-title":"Int J Mol Sci"},{"key":"2000_CR15","doi-asserted-by":"publisher","unstructured":"Sj LPYL, Kc K, Kj S, Ka Y. Regulation of OPA1-mediated mitochondrial fusion by leucine zipper\/EF-hand-containing transmembrane protein-1 plays a role in apoptosis. Cell Signal. 2009;21. https:\/\/doi.org\/10.1016\/j.cellsig.2009.01.020.","DOI":"10.1016\/j.cellsig.2009.01.020"},{"key":"2000_CR16","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1126\/science.1062030","volume":"294","author":"SM Maira","year":"2001","unstructured":"Maira SM, Galetic I, Brazil DP, Kaech S, Ingley E, Thelen M, et al. Carboxyl-terminal modulator protein (CTMP), a negative regulator of PKB\/Akt and v-Akt at the plasma membrane. Science. 2001;294:374\u201380. https:\/\/doi.org\/10.1126\/science.1062030.","journal-title":"Science"},{"key":"2000_CR17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2121-10-53","volume":"10","author":"L Piao","year":"2009","unstructured":"Piao L, Li Y, Yang K-J, Park KA, Byun HS, Won M, et al. Heat shock protein 70-mediated sensitization of cells to apoptosis by carboxyl-terminal modulator protein. BMC Cell Biol. 2009;10:53. https:\/\/doi.org\/10.1186\/1471-2121-10-53.","journal-title":"BMC Cell Biol"},{"key":"2000_CR18","doi-asserted-by":"publisher","first-page":"29699","DOI":"10.18632\/oncotarget.10719","volume":"8","author":"Y-C Chen","year":"2017","unstructured":"Chen Y-C, Li H-Y, Liang J-L, Ger L-P, Chang H-T, Hsiao M, et al. CTMP, a predictive biomarker for trastuzumab resistance in HER2-enriched breast cancer patient. Oncotarget. 2017;8:29699\u2013710. https:\/\/doi.org\/10.18632\/oncotarget.10719.","journal-title":"Oncotarget"},{"key":"2000_CR19","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1038\/s41417-022-00559-x","volume":"30","author":"C-H Lin","year":"2023","unstructured":"Lin C-H, Lin W-D, Huang Y-C, Chen Y-C, Loh Z-J, Ger L-P, et al. Carboxyl-terminal modulator protein facilitates tumor metastasis in triple-negative breast cancer. Cancer Gene Ther. 2023;30:404\u201313. https:\/\/doi.org\/10.1038\/s41417-022-00559-x.","journal-title":"Cancer Gene Ther"},{"key":"2000_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/srep28503","volume":"6","author":"JW Chang","year":"2016","unstructured":"Chang JW, Jung S-N, Kim J-H, Shim G-A, Park HS, Liu L, et al. Carboxyl-terminal modulator protein positively acts as an oncogenic driver in head and neck squamous cell carcinoma via regulating Akt phosphorylation. Sci Rep. 2016;6:28503. https:\/\/doi.org\/10.1038\/srep28503.","journal-title":"Sci Rep"},{"key":"2000_CR21","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1007\/s11064-016-1932-y","volume":"41","author":"Y Chen","year":"2016","unstructured":"Chen Y, Cai M, Deng J, Tian L, Wang S, Tong L, et al. Elevated expression of carboxy-terminal modulator protein (CTMP) aggravates brain ischemic injury in diabetic db\/db mice. Neurochem Res. 2016;41:2179\u201389. https:\/\/doi.org\/10.1007\/s11064-016-1932-y.","journal-title":"Neurochem Res"},{"key":"2000_CR22","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1093\/jnci\/djh064","volume":"96","author":"CB Knobbe","year":"2004","unstructured":"Knobbe CB, Reifenberger J, Blaschke B, Reifenberger G. Hypermethylation and transcriptional downregulation of the carboxyl-terminal modulator protein gene in glioblastomas. J Natl Cancer Inst. 2004;96:483\u20136. https:\/\/doi.org\/10.1093\/jnci\/djh064.","journal-title":"J Natl Cancer Inst"},{"key":"2000_CR23","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1164\/rccm.200810-1553OC","volume":"179","author":"S-K Hwang","year":"2009","unstructured":"Hwang S-K, Lim H-T, Minai-Tehrani A, Lee E-S, Park J, Park SB, et al. Repeated aerosol delivery of carboxyl-terminal modulator protein suppresses tumor in the lungs of K-rasLA1 mice. Am J Respir Crit Care Med. 2009;179:1131\u201340. https:\/\/doi.org\/10.1164\/rccm.200810-1553OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2000_CR24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1097\/CAD.0000000000001301","volume":"33","author":"F Niu","year":"2022","unstructured":"Niu F, Duan Y, Man Y, Liu W, Dai T, Zhang H, et al. Mitochondrial protein LETM1 and its-mediated CTMP are potential therapeutic targets for endometrial cancer. Anticancer Drugs. 2022;33:632\u201341. https:\/\/doi.org\/10.1097\/CAD.0000000000001301.","journal-title":"Anticancer Drugs"},{"key":"2000_CR25","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3760\/cma.j.cn112151-20220322-00212","volume":"51","author":"Committee on Pathology, Chinese Society of Obstetrics and Gynecology, Committee on Female Reproductive System Disease, Chinese Society of Pathology, Department of Gynecology and Pediatrics, Ultramicro and Molecular Pathology Branch, Chinese Research Hospital Society","year":"2022","unstructured":"Committee on Pathology, Chinese Society of Obstetrics and Gynecology, Committee on Female Reproductive System Disease, Chinese Society of Pathology, Department of Gynecology and Pediatrics, Ultramicro and Molecular Pathology Branch, Chinese Research Hospital Society. [Expert consensus on pathological evaluation of endometrial carcinomas before and after conservation therapy]. Zhonghua Bing Li Xue Za Zhi. 2022;51:1110\u20134. https:\/\/doi.org\/10.3760\/cma.j.cn112151-20220322-00212.","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"2000_CR26","first-page":"1103","volume":"37","author":"M Nishida","year":"1985","unstructured":"Nishida M, Kasahara K, Kaneko M, Iwasaki H, Hayashi K. [Establishment of a new human endometrial adenocarcinoma cell line, Ishikawa cells, containing Estrogen and progesterone receptors]. Nihon Sanka Fujinka Gakkai Zasshi. 1985;37:1103\u201311.","journal-title":"Nihon Sanka Fujinka Gakkai Zasshi"},{"key":"2000_CR27","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ygyno.2004.09.057","volume":"96","author":"KK Leslie","year":"2005","unstructured":"Leslie KK, Stein M-P, Kumar NS, Dai D, Stephens J, Wandinger-Ness A, et al. Progesterone receptor isoform identification and subcellular localization in endometrial cancer. Gynecol Oncol. 2005;96:32\u201341. https:\/\/doi.org\/10.1016\/j.ygyno.2004.09.057.","journal-title":"Gynecol Oncol"},{"key":"2000_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-7-150","volume":"7","author":"K Tamm","year":"2009","unstructured":"Tamm K, R\u00f5\u00f5m M, Salumets A, Metsis M. Genes targeted by the estrogen and progesterone receptors in the human endometrial cell lines HEC1A and RL95-2. Reprod Biol Endocrinol. 2009;7:150. https:\/\/doi.org\/10.1186\/1477-7827-7-150.","journal-title":"Reprod Biol Endocrinol"},{"key":"2000_CR29","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ygyno.2011.11.043","volume":"125","author":"J Baker","year":"2012","unstructured":"Baker J, Obermair A, Gebski V, Janda M. Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature. Gynecol Oncol. 2012;125:263\u201370. https:\/\/doi.org\/10.1016\/j.ygyno.2011.11.043.","journal-title":"Gynecol Oncol"},{"key":"2000_CR30","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/1471-0528.17331","volume":"130","author":"WJ van Weelden","year":"2023","unstructured":"van Weelden WJ, Birkendahl PB, Lalisang RI, IntHout J, Kruitwagen RFPM, Romano A, et al. The effect of progestin therapy in advanced and recurrent endometrial cancer: a systematic review and meta-analysis. BJOG: An International Journal of Obstetrics & Gynaecology. 2023;130:143\u201352. https:\/\/doi.org\/10.1111\/1471-0528.17331.","journal-title":"BJOG: An International Journal of Obstetrics & Gynaecology"},{"key":"2000_CR31","doi-asserted-by":"publisher","unstructured":"Ai Z, Wang J, Wang Y, Lu L, Tong J, Teng Y. Overexpressed epidermal growth factor receptor (EGFR)-induced progestin insensitivity in human endometrial carcinoma cells by the EGFR\/mitogen-activated protein kinase signaling pathway. Cancer. 2010;116:3603\u201313. https:\/\/doi.org\/10.1002\/cncr.25220.","DOI":"10.1002\/cncr.25220"},{"key":"2000_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/bcr452","volume":"4","author":"E Anderson","year":"2002","unstructured":"Anderson E. The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis. Breast Cancer Res BCR. 2002;4:197\u2013201. https:\/\/doi.org\/10.1186\/bcr452.","journal-title":"Breast Cancer Res BCR"},{"key":"2000_CR33","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2024.13282","volume":"30","author":"H Nguyen","year":"2024","unstructured":"Nguyen H, Kim S-H, Juang U, Gwon S, Jung W, Huang Q, et al. Overview of carboxyl\u2013terminal modulator protein 1 and its importance in various metabolic regulations (Review). Mol Med Rep. 2024;30:158. https:\/\/doi.org\/10.3892\/mmr.2024.13282.","journal-title":"Mol Med Rep"},{"key":"2000_CR34","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.cellsig.2009.01.016","volume":"21","author":"A Parcellier","year":"2009","unstructured":"Parcellier A, Tintignac LA, Zhuravleva E, Cron P, Schenk S, Bozulic L, et al. Carboxy-terminal modulator protein (CTMP) is a mitochondrial protein that sensitizes cells to apoptosis. Cell Signal. 2009;21:639\u201350. https:\/\/doi.org\/10.1016\/j.cellsig.2009.01.016.","journal-title":"Cell Signal"},{"key":"2000_CR35","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.bbrc.2023.01.023","volume":"644","author":"J Wang","year":"2023","unstructured":"Wang J, Tierney L, Wilson C, Phillips V, Goldman L, Mumaw C, et al. Carboxyl-terminal modulator protein (CTMP) deficiency mitigates denervation-induced skeletal muscle atrophy. Biochem Biophys Res Commun. 2023;644:155\u201361. https:\/\/doi.org\/10.1016\/j.bbrc.2023.01.023.","journal-title":"Biochem Biophys Res Commun"},{"key":"2000_CR36","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s12035-014-8710-0","volume":"51","author":"C-Y Huang","year":"2015","unstructured":"Huang C-Y, Chen J-J, Wu J-S, Tsai H-D, Lin H, Yan Y-T, et al. Novel link of anti-apoptotic ATF3 with pro-apoptotic CTMP in the ischemic brain. Mol Neurobiol. 2015;51:543\u201357. https:\/\/doi.org\/10.1007\/s12035-014-8710-0.","journal-title":"Mol Neurobiol"},{"key":"2000_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY, Yap KCH, Jacot W, Jones RH, et al. PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer. 2023;22:138. https:\/\/doi.org\/10.1186\/s12943-023-01827-6.","journal-title":"Mol Cancer"},{"key":"2000_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03448-5","volume":"24","author":"Y Cheng","year":"2024","unstructured":"Cheng Y, Lu Y, Xue J, Wang X, Zhou L, Luo Y, et al. DDX19A promotes gastric cancer cell proliferation and migration by activating the PI3K\/AKT pathway. Cancer Cell Int. 2024;24:272. https:\/\/doi.org\/10.1186\/s12935-024-03448-5.","journal-title":"Cancer Cell Int"},{"key":"2000_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06624-7","volume":"15","author":"A Li","year":"2024","unstructured":"Li A, Wang S, Nie J, Xiao S, Xie X, Zhang Y, et al. USP3 promotes osteosarcoma progression via deubiquitinating EPHA2 and activating the PI3K\/AKT signaling pathway. Cell Death Dis. 2024;15:235. https:\/\/doi.org\/10.1038\/s41419-024-06624-7.","journal-title":"Cell Death Dis"},{"key":"2000_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3760\/cma.j.issn.0253-2727.2019.01.010","volume":"40","author":"J Wu","year":"2019","unstructured":"Wu J, Lu AD, Zhang LP, Zuo YX, Jia YP. [Study of clinical outcome and prognosis in pediatric core binding factor-acute myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi. 2019;40:52\u20137. https:\/\/doi.org\/10.3760\/cma.j.issn.0253-2727.2019.01.010.","journal-title":"Zhonghua Xue Ye Xue Za Zhi Zhonghua Xueyexue Zazhi"},{"issue":"1","key":"2000_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-52940-5","volume":"14","author":"M Entezari","year":"2024","unstructured":"Entezari M, Soltani BM, Sadeghizadeh M. Microrna-203a inhibits breast cancer progression through the PI3K\/Akt and Wnt pathways. Sci Rep. 2024;14(1):4715. https:\/\/doi.org\/10.1038\/s41598-024-52940-5.","journal-title":"Sci Rep"},{"key":"2000_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-024-05123-x","author":"C Jin","year":"2024","unstructured":"Jin C, Gao X, Ni J, Zhang B, Wang Z. MiR-592 attenuates Tamoxifen resistance in breast cancer through PIK3CA-mediated PI3K\/AKT\/mTOR signaling pathway. Appl Biochem Biotechnol. 2024. https:\/\/doi.org\/10.1007\/s12010-024-05123-x.","journal-title":"Appl Biochem Biotechnol"},{"key":"2000_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-024-04748-3","volume":"95","author":"K Zheng","year":"2025","unstructured":"Zheng K, Jin G, Cao R, Gao Y, Xu J, Chai R, et al. Targeting on the PI3K\/mTOR: a potential treatment strategy for clear cell ovarian carcinoma. Cancer Chemother Pharmacol. 2025;95:21. https:\/\/doi.org\/10.1007\/s00280-024-04748-3.","journal-title":"Cancer Chemother Pharmacol"},{"key":"2000_CR44","doi-asserted-by":"publisher","unstructured":"Zhou Q, Li W, Kong D, Liu Z, Shi Z, Ma X, et al. DACH1 suppresses epithelial to mesenchymal transition (EMT) through Notch1 pathway and reverses progestin resistance in endometrial carcinoma. Cancer Med 2019;8:4380\u20138. https:\/\/doi.org\/10.1002\/cam4.2317.","DOI":"10.1002\/cam4.2317"},{"key":"2000_CR45","unstructured":"Yang B, Hu M, Fu Y, Sun D, Zheng W, Liao H, et al. LASS2 mediates Nrf2-driven progestin resistance in endometrial cancer. Am J Transl Res. 2021;13:1280\u20139.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/33841656\/."},{"key":"2000_CR46","unstructured":"Fan R, Wang Y, Wang Y, Wei L, Zheng W. Mechanism of progestin resistance in endometrial precancer\/cancer through Nrf2-survivin pathway. Am J Transl Res. 2017;9:1483\u201391. https:\/\/pubmed.ncbi.nlm.nih.gov\/28386373\/."},{"key":"2000_CR47","doi-asserted-by":"publisher","first-page":"6194","DOI":"10.1158\/0008-5472.CAN-13-0518","volume":"73","author":"Y-P Liu","year":"2013","unstructured":"Liu Y-P, Liao W-C, Ger L-P, Chen J-C, Hsu T-I, Lee Y-C, et al. Carboxyl-terminal modulator protein positively regulates Akt phosphorylation and acts as an oncogenic driver in breast cancer. Cancer Res. 2013;73:6194\u2013205. https:\/\/doi.org\/10.1158\/0008-5472.CAN-13-0518.","journal-title":"Cancer Res"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-02000-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-025-02000-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-02000-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T20:02:14Z","timestamp":1766088134000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-025-02000-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":47,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2000"],"URL":"https:\/\/doi.org\/10.1007\/s43032-025-02000-8","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"type":"print","value":"1933-7191"},{"type":"electronic","value":"1933-7205"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"6 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants prior to biopsy procedure and was approved by Shandong Provincial Hospital Affiliated to Shandong First Medical University (Approve No.SWYX2025-009).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}